ARTICLES

Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.

Why Product Demand Matters More to PBMs Than Manufacturers Think

Does coverage create demand, or can demand shape coverage? Harris Kaplan explores why strong physician and patient demand may matter more to PBMs than manufacturers realize.

Sep 151 min read

Managing Partner, Harris Kaplan, published in BioSpace: Why KOL Enthusiasm Often Doesn’t Predict Commercial Success

KOL enthusiasm can signal early promise, but it rarely tells the full story. Harris Kaplan examines why expert advocacy often fails to translate into market adoption—and what life sciences teams should evaluate instead.

Apr 221 min read

Pyramid diagram of Maslow's Hierarchy: Food, Security, Social needs, Accomplishment, Potential. Arrow labeled Immediate Importance points up.

Managing Partner, Harris Kaplan, published in PharmExec: Marketers - Physicians are People First

Harris Kaplan , Managing Partner, just published an article in PharmExec (titled Marketers: Physicians are People First ) that looks at...

Nov 17, 20201 min read

Virtual Health Care: Where Does This Leave Pharma Marketing?

Managing partner, Harris Kaplan , participated in Pharma intelligence ‘s 24-hour web event on COVID-19: Lessons Learned and a Path...

Aug 31, 20201 min read

Join us for Informa’s 24-Hour Web Event – COVID-19: Lesson Learned and a Path Forward

We are pleased to announce that Harris Kaplan , Managing Partner, will be participating in a new 24-hour web event , hosted by Informa...

Jun 30, 20201 min read

Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Harris Kaplan , Managing Partner, has partnered with Fred Dotzler to write the cover story for In Vivo January 2019. The article delves into what payers are doing in today’s world to try to control the cost of new life science products, and what steps they plan on taking to better control rising costs in the future. Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Jan 16, 20191 min read

Mail